UBS shares are on an upward trend, reaching EUR 29.72 on November 28, marking a 0.24% increase. RBC maintains an "outperform" rating with a target price of 32 francs, while the bank's earnings per share improved significantly to CHF 0.39, up from CHF -0.21 last year. UBS has a market capitalization of 102.6 billion euros and declared a dividend of USD 0.35 this year.
The Healthcare Revenue Cycle Management market is poised for significant growth, driven by rising demand across various industries and technological advancements. A comprehensive report analyzes market dynamics, competitive landscapes, and future trends, highlighting key players like GE Healthcare and Mckesson Corporation. It also explores challenges such as supply chain disruptions and changing consumer preferences, providing valuable insights for market participants.
AstraZeneca’s Enhertu, a leading breast cancer treatment, has been approved for reimbursement by China’s state-run medical insurance, enhancing the company’s sales prospects amid an ongoing investigation involving some senior executives. The drug is one of 91 added to the National Reimbursement Drug List, effective January 1, alongside treatments from Johnson & Johnson, Bristol Myers Squibb, Roche, Sanofi, and Merck for various conditions.
ICICI Securities has recommended a "BUY" rating for Aadhar Housing Finance, setting a target price of INR 550. The company has shown strong performance with an 18% AUM CAGR from FY18 to FY24, reaching INR 228 billion, supported by its extensive branch network and strategic market diversification. Aadhar's growth has been achieved at a higher spread of approximately 6%, outperforming peers.
Investors are increasingly avoiding French assets amid rising political tensions, fearing ongoing instability. The upcoming S&P Global Ratings assessment adds to the uncertainty surrounding the budget and the government, contributing to higher borrowing costs and a significant drop in stock performance, marking the worst year relative to European shares since 2010.
Hackers breached the Bank of Uganda, stealing 62 billion shillings ($17 million) from its accounts. The attack was attributed to a Southeast Asian group known as “Waste.” The bank has since recovered approximately 37 billion shillings of the stolen funds.
OPEC+ has postponed its meeting to decide on oil production strategy to December 5, shifting from the original date of December 1. The coalition is currently implementing three sets of production cuts, totaling 39.725 million barrels per day, amid uncertain demand and fluctuating global oil prices.
UBS has reduced its price target for Vestas from 245 to 175 Danish crowns while maintaining a "Buy" rating. Analyst Supriya Subramanian noted that disappointing margins in recent quarters and the US presidential election results are likely already reflected in the stock price, although earnings forecasts for 2024 to 2026 have been significantly lowered.
Motilal Oswal maintains a Neutral rating on Colgate with a target price of Rs 3,250, highlighting the company's strong strategic pillars for growth in oral care. While urban toothpaste volume growth has decelerated, rural markets are showing positive trends, with expectations of 9% to 11% CAGR in sales and profits from FY24 to FY27.
BAWAG Group AG, with a market capitalization of €5.78 billion, generates revenues primarily from Retail & SME (€1.08 billion) and has a dividend yield of 6.79%. Despite steady earnings growth, the company faces challenges with a high non-performing loan ratio of 2% and a volatile dividend history.